AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer

NCT04630756 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Haematological Malignancies

Interventions

DRUG: AZD4573
DRUG: Acalabrutinib

Sponsor

AstraZeneca

Collaborators

[object Object]